Advertisement
Advertisement
ABT
Abbott Laboratories
111.27
USDSponsored
+0.36
+0.32%
Aug 13, 15:59 UTC -4
Closed
Pre-Market
111.52
+0.25
+0.22%
ABT Earnings Reports
Positive Surprise Ratio
ABT beat 30 of 42 last estimates.
71%
Next Report
Date of Next Report
Oct 13, 2026
Estimate for Q3 26 (Revenue/ EPS)
$13.13B
/$1.43
Implied change from Q2 26 (Revenue/ EPS)
+4.27%
/+9.16%
Implied change from Q3 25 (Revenue/ EPS)
+15.50%
/+10.00%
Abbott Laboratories earnings per share and revenue
On Jul 16, 2026, ABT reported earnings of 1.31 USD per share (EPS) for Q2 26, beating the estimate of 1.29 USD, resulting in a 1.38% surprise. Revenue reached 12.59 billion, compared to an expected 12.63 billion, with a -0.27% difference. The market reacted with a +10.71% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 24 analysts forecast an EPS of 1.43 USD, with revenue projected to reach 13.13 billion USD, implying an increase of 9.16% EPS, and increase of 4.27% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.16
Actual
$0.20
Surprise
+24.07%
Omeros Corporation
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.27
Actual
$0.02
Surprise
+107.31%
Brainsway Ltd. - ADR
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.15
Actual
$0.14
Surprise
-7.65%
Valneva SE - ADR
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.34
Surprise
-243.33%
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
Capricor Therapeutics Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.70
Surprise
-16.32%
Organigram Global Inc. Common Shares
Report Date
Aug 11, 2026 For Q3 26
Estimate
$0.00
Actual
-$0.06
Surprise
-2,480.74%
Immucell Corp
Report Date
Aug 13, 2026 For Q2 26
Estimate
-Actual
$0.20
Surprise
-
FitLife Brands, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.19
Actual
$0.20
Surprise
+0.55%
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
FAQ
What were Abbott Laboratories's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Abbott Laboratories reported EPS of $1.31, beating estimates by 1.38%, and revenue of $12.59B, -0.27% below expectations.
How did the market react to Abbott Laboratories's Q2 2026 earnings?
The stock price moved up 10.71%, changed from $89.27 before the earnings release to $98.83 the day after.
When is Abbott Laboratories expected to report next?
The next earning report is scheduled for Oct 13, 2026.
What are the forecasts for Abbott Laboratories's next earnings report?
Based on 24
analysts, Abbott Laboratories is expected to report EPS of $1.43 and revenue of $13.13B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement